Clinical trials
Phase 1 Leishmaniasis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2005 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Terminated | 3 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Access to Advanced Health Institute (AAHI) | 5 |
| GlaxoSmithKline | 2 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 1 |
| Universidad de Antioquia | 1 |
| University Hospital Tuebingen | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leishmaniasis | 10 |
| Leishmaniasis, Cutaneous | 3 |
| Leishmaniasis, Mucocutaneous | 1 |
| Leishmaniasis, Visceral | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.